|
What Some People Are Saying About Us
|
"We are planning to pursue this each year, as long as we have products that qualify for the act...I would strongly recommend it. I have already recommended [Paradigm] to numerous business owners."
Jerry Lawson
CEO
WW Wood, Inc.
|
 About Us
Paradigm Partners is an international consulting firm specializing in complex federal and state tax and funding incentives, for both public and private entities, across a host of industries. Paradigm Partners has distinguished itself among its peers by adopting a low cost, high return service model that employs a tailored two-phase approach. The Company's business development and professional teams work hand in hand to provide accurate analyses, establish effective client dialogues, and guarantee rapid turnaround times.
Paradigm's staff is comprised of a highly selective pool of intellectual property and tax attorneys, engineers, PhDs, and CPAs. Company personnel utilize not only years of industry expertise, but their numerous academic achievements from distinguished institutions across the globe.
The Company's core consulting portfolio includes Global R&D Tax Credits Analyses, Hiring and Location- Based Incentives, Unemployment Claims Management, IC-DISC, Domestic Production Deduction, Grant and Non-dilutive Funding Advisory, Cost Segregation Studies, Tax Controversy, Patent and Audit Defense Services.
|
|
|
|
|
 |
|
Research and Tax Incentives for the Manufacturing, Engineering, Architectural and Construction Industries
by
Zee Makhani, Director and Karim Solanji, Director
The R&D Tax Credit is a highly complex and frequently misunderstood tax incentive. While a diverse field of clients may be qualified for the credit, it is one of the most underutilized tax incentives available due to misconceptions about the definition of "research and development."
This is particularly true of the manufacturing, engineering, architectural and construction industries.
In large part, these misconceptions come from the idea that common industry practices cannot be qualified activities under the definition of "research and development" provided in the Internal Revenue Code (IRC).
It is not necessary to have a dedicated R&D division, a laboratory, or a degreed engineer on staff because, while these may be indicative of ongoing R&D, the definition of "research and development" was left intentionally expansive.
This allows for qualification of projects and activities to be done on a case by case basis, ensuring that even less obvious projects and activities can be captured for the credit.
Click Here to Read the Full Article
Contact Brian Cameron at 281-558-7100 or
to learn more about an R&D Tax Credit study.
|
NIH Grants - Alternative Funding for Biotech Start-ups
by Melanie Neely Willis, Director of Grants and Contracts The recession and its aftermath have resulted in a steep decline in venture capital investment in start-ups. Medical device and biotechnology start-ups have been particularly hard-hit with a 39% decline in funding dollars in 2012 alone. In such an environment, start-ups must have a competitive edge to survive. The early stages of business development are critical. Defining key products and generating proof-of-concept data are essential to survival. However, investors are hesitant to commit support until feasibility is demonstrated, leaving a funding gap in the biotech start-up life cycle. Fortunately, the National Institute of Health provides millions of dollars of non-dilutive funding each year to early stage biotech and medical device start-ups. Contact Jacob Setterbo at 281-558-7100 or to learn more about various grant opportunities. |
|
|
